Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent Reform Legislation Introduced; Damages, Inequitable Conduct In Flux

Executive Summary

Senate language from the patent reform debate in the last Congress will be the starting point this year for negotiations on how to calculate a reasonable royalty for patent infringement

You may also be interested in...



Patent Reform: Brands Get Damages, Generics Have Inequitable Conduct

Patent reform legislation exited the Senate Judiciary Committee April 2 without apportionment of damages or inequitable conduct language, providing both brand and generic pharmaceutical companies with something to like

Patent Reform: Brands Get Damages, Generics Have Inequitable Conduct

Patent reform legislation exited the Senate Judiciary Committee April 2 without apportionment of damages or inequitable conduct language, providing both brand and generic pharmaceutical companies with something to like

Full House Judiciary Panel Getting Into The Patent Act: IP Issues Will No Longer Go Through Subcmte.

Change in jurisdiction eliminates one round of legislative review, gives Chairman Conyers direct control of issue.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel